Tetraxime

Tetraxime
  • Contraindication

    Contraindications: hypersensitivity to any component of the vaccine or reaction to the component of whooping cough, if complications were detected after previous vaccination, in case of illness accompanied by fever, in the presence of a history of progressive encephalopathy, convulsions.

  • Side effects

    Side effects: drowsiness, diarrhea, possible vomiting, fever, redness, thickening at the injection site, pain at the injection site may be observed after vaccination. In the presence of mechanical inclusions or a strange color of the suspension, the use of the vaccine is unacceptable.

Tetraxime

Not available
  • Producing country:France
  • Composition and form of release:suspension for injection.

Against what:
In what vaccinations is it used?:

Application

Application: the vaccine should be administered intramuscularly in a dose of 0.5 ml, in the area of the thigh or deltoid muscle. It is strictly forbidden to administer the vaccine intravenously, subcutaneously and intradermally. Before vaccination, it is recommended to examine the child, exclude contact with SARS patients. Patients should be under medical supervision within 30 minutes after the vaccine is administered.

  • Indication

    Indications: the vaccine is used for primary immunization of children from 3 months of age against diphtheria, tetanus, whooping cough, poliomyelitis, for revaccination.